What are the next steps in managing a 32-year-old woman with persistent constipation despite daily lactulose (Emolax) and two bedtime tablets of senna (Senior)?

Switch to Polyethylene Glycol (PEG) Immediately

Your patient has failed first-line therapy with lactulose and senna, so you should switch to polyethylene glycol (PEG), which has a strong recommendation as the most effective osmotic laxative for chronic constipation. 1

Why Current Therapy is Failing

Your patient is on two agents that received only conditional recommendations in the 2023 AGA-ACG guidelines:

• Lactulose (Emolax): Conditional recommendation - weaker evidence base 1
• Senna (Senior): Conditional recommendation - less robust efficacy data 1

The combination of these two conditionally-recommended agents is not providing adequate relief, which occurs in approximately 50% of patients treated with conventional laxatives 2.

Immediate Next Step: Switch to PEG

Polyethylene glycol received a STRONG recommendation from the 2023 AGA-ACG guidelines - the highest level of evidence among all laxatives 1. This means:

• Superior efficacy: PEG demonstrated better outcomes than lactulose in head-to-head trials (1.3 vs 0.9 bowel movements per day, P = 0.005) 3
• Better tolerability: Fewer side effects compared to lactulose
• Cost-effective: Available over-the-counter

Dosing Strategy

• Start PEG 17g (one capful) daily, mixed in 8 oz of liquid
• Can titrate up to twice daily if needed
• Takes 1-3 days to work

If PEG Fails: Escalate to Prescription Agents

If your patient doesn't respond adequately to PEG after 1-2 weeks, escalate to agents with strong recommendations 1:

First-line prescription options (all have strong recommendations):

1. Linaclotide (secretagogue) - improves both motility AND abdominal symptoms
2. Plecanatide (secretagogue) - similar mechanism to linaclotide
3. Prucalopride (5-HT4 agonist) - prokinetic agent
4. Sodium picosulfate (stimulant laxative) - stronger than senna

Linaclotide or plecanatide are particularly valuable because they address sensory symptoms (bloating, discomfort) that conventional laxatives don't manage well 2.

Critical Pitfalls to Avoid

Before changing medications, verify:

• No red flags: The FDA label for Emolax warns to stop and evaluate if there's rectal bleeding, worsening abdominal pain, or need for laxatives >1 week 4
• Rule out secondary causes: Medications (opioids, anticholinergics), hypothyroidism, hypercalcemia, diabetes 5
• Digital rectal exam: Rule out fecal impaction - if present, treat with enema first before adjusting oral laxatives 6
• Adequate trial duration: Ensure she's taken current regimen consistently for at least 1-2 weeks

Common mistakes in young adults with constipation:

• Inadequate fluid intake: Must drink adequate water with any laxative
• Insufficient fiber: Should aim for 25-30g daily (but add slowly to avoid bloating)
• Ignoring lifestyle factors: Regular exercise, scheduled toilet time after meals 5

Important Caveat About "Senior"

Note: The FDA label you have for "Senior" appears to be for prednisolone (a corticosteroid) 7, not senna. If your patient is actually taking prednisolone, this could be causing her constipation as a medication side effect. Verify what "Senior" actually contains - if it's a corticosteroid, address the underlying indication and consider whether it can be reduced or discontinued.

Algorithm Summary

1. Verify diagnosis: Digital rectal exam, rule out impaction and secondary causes
2. Switch from lactulose + senna → PEG (strong recommendation) 1
3. Trial PEG for 1-2 weeks with adequate hydration
4. If inadequate response → Add or switch to secretagogue (linaclotide/plecanatide) or prucalopride 1
5. Consider referral if no response to prescription agents - may need anorectal manometry to evaluate for pelvic floor dysfunction 5